VitaNova Life Sciences Corporation (VNOV)

OTCMKTS · Delayed Price · Currency is USD

3.000

-1.476 (-32.98%)

Oct 29, 2026, 12:37 PM EDT

VitaNova Life Sciences Financials Overview

Financials in millions USD. Fiscal year is May - April.

Millions USD. Fiscal year is May - Apr.

Revenue & Profits

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul '26 Jul 31, 2026	Apr '26 Apr 30, 2026	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022
Revenue	3.24	3.03	2.66	0.57	0.04	0.12
Revenue Growth	22.04%	13.65%	366.47%	1401.83%	-68.33%	-
Gross Profit	0.87	0.91	1.58	0.38	0.04	0.12
Operating Income	-0.09	0	1.21	0.21	-0.02	-0.01
Net Income	-0.11	-0.04	0.85	0.14	-0.02	0.14
Earnings Per Share	-0.01	-0.00	0.10	0.04	-0.01	0.06
EPS Growth	-	-	157.00%	-	-	-

Revenue by Segment

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul '26 Jul 31, 2026	Apr '26 Apr 30, 2026	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022
Healthy Food Products	-	1.06	-	-	-	-
Dietary Supplement Segment	1.93	1.95	2.65	0.54	-	-
Consulting Services Segment	-	0.02	0.01	0.03	0.04	0.12
Total	3.24	3.03	2.66	0.57	0.04	0.12

Cash & Debt

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul '26 Jul 31, 2026	Apr '26 Apr 30, 2026	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022
Cash & Investments	1.6	1.6	0.78	0.59	0.01	0.02
Total Debt	-	-	-	0	0.02	0.01
Net Cash (Debt)	1.6	1.6	0.78	0.59	-0.01	0.01
Net Cash Growth	53.27%	104.04%	32.67%	-	-	-
Net Cash Per Share	0.19	0.19	0.09	0.17	-0.00	0.01

Cash Flow & CapEx

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul '26 Jul 31, 2026	Apr '26 Apr 30, 2026	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022
Operating Cash Flow	0.56	0.81	0.19	-0.38	-0.02	0
Capital Expenditures	-	-	-	-	-	-
Free Cash Flow	0.56	0.81	0.19	-0.38	-0.02	0
Free Cash Flow Growth	-41.96%	322.47%	-	-	-	-

Margins

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul '26 Jul 31, 2026	Apr '26 Apr 30, 2026	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022
Gross Margin	26.90%	30.10%	59.19%	66.19%	100.00%	100.00%
Operating Margin	-2.66%	0.12%	45.39%	36.03%	-63.75%	-11.14%
Pretax Margin	-2.56%	0.22%	45.24%	36.05%	-63.76%	116.40%
Profit Margin	-3.52%	-1.23%	31.96%	24.68%	-63.75%	116.40%
FCF Margin	17.19%	26.92%	7.24%	-65.86%	-48.35%	3.38%

Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct '26 Oct 30, 2026	Apr '26 Apr 30, 2026	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022
PE Ratio	-	-	5.29	106.54	-	21.44
P/FCF Ratio	44.86	14.13	23.36	-	-	737.34
PS Ratio	7.71	3.80	1.69	26.30	463.52	24.95